The Eye Is a Window Into the Brain. We Built the Camera.
The oculomotor system — the neural machinery that controls eye movement — is the most neurologically dense sensorimotor system in the human body. It integrates input from the frontal cortex, cerebellum, brainstem, basal ganglia, vestibular nuclei, and autonomic nervous system in real time.
When any of those systems are disrupted — by trauma, fatigue, substance, disease, or medication — the eye movement record changes in quantifiable, reproducible ways. ClearGazeTest captures those changes with infrared video oculography at 500 Hz and translates them into 12 clinically actionable biomarkers in 5 minutes.
Real-Time Functional Assessment
Measures current neurological state — not past exposure. The question answered is "is this person impaired right now?" — which no blood or urine test can address.
Quantitative, Not Observational
Every result is a number — not a clinician's subjective impression. 182 ms saccadic latency is objective. "Looks a little slow" is not. Courts, regulators, and physicians need the former.
Longitudinal Baseline Architecture
Every assessment builds on the last. Individual baseline deviation is more sensitive than population norms alone — enabling detection of subtle change across a career, season, or treatment course.
Seven Markets. One Platform.
A single, scalable technology infrastructure addresses some of the most underserved neurological assessment needs across healthcare, safety, defense, and law.
Assessment Market
reported annually (US)
annual economic cost
cannabis & no impairment test
requiring monitoring
Every Major Neurological Assessment Gap. Addressed.
Each market represents a distinct, underserved need - unified by a single platform that speaks the language of each audience.
"Oculomotor assessment is the EKG of the brain - objective, real-time, and impossible to fake. Every major neurological condition leaves a signature in the eye movement record. We now have the technology to read it in 5 minutes."
Five Minutes. Twelve Biomarkers. One Clear Answer.
The same platform, the same protocol, the same technology — applied across every market in the ClearGazeTest suite.
Establish Baseline
Pre-season, pre-deployment, or first-visit calibration creates an individual neurological reference. Future assessments compare to personal baseline — far more sensitive than population norms alone.
5-Minute Assessment
Automated stimulus battery administered by non-specialist staff. No physician presence required. No patient preparation, no radiation, no discomfort. Results before the patient leaves the chair.
Automated Scoring
500 Hz infrared capture is processed algorithmically. All 12 biomarker values computed and ranked against individual baseline and age-stratified population norms. No manual scoring.
Actionable Report
Structured PDF with biomarker values, trend analysis, normative comparison, and plain-language summary. HL7 FHIR export for EHR integration. Designed for clinical, legal, and regulatory documentation.
A Single Platform Addressing Multiple Billion-Dollar Market Gaps
ClearGazeTest represents a rare convergence: a validated scientific modality (oculomotor neuroscience), a scalable technology platform (infrared VOG), and a portfolio of underserved markets with urgent, documented, unmet needs.
Platform leverage: One technology investment addresses seven distinct verticals — healthcare, law enforcement, workplace safety, defense, geriatrics, and sports medicine. Each market generates independent revenue without requiring separate technology development.
Regulatory tailwind: Cannabis legalization across 38 states has created an acute enforcement and liability gap that no current technology addresses. ClearGazeTest is uniquely positioned as the objective impairment measurement solution that law, workplace policy, and clinical practice all require.
Defensible data moat: Every assessment adds to the longitudinal biomarker database. Population-level oculomotor data across clinical, occupational, and military populations creates a normative intelligence asset that compounds in value over time.
Clinical anchor: Medical Card Exam provides an established clinical partner for deployment, regulatory navigation, and physician-supervised implementation across markets requiring licensed medical oversight.
Recurrent revenue model: Per-assessment SaaS pricing across institutional clients (hospitals, sports organizations, employers, law enforcement agencies) creates predictable, recurring revenue at scale.
Request a Clinical Demo
Speak with a ClearGazeTest clinical specialist. See sample reports, discuss workflow integration, and learn how the platform serves your specific specialty and patient population.
Clinical Inquiry →Investor Briefing
Explore the market opportunity, platform architecture, and growth strategy across all seven verticals. Contact our team at Medical Card Exam to schedule a confidential briefing.
Schedule Briefing →